Logo
x

Search

Subscribe Now

csl

CSL and Arcturus Therapeutics Report the EC’s Approval of Kostaive Against COVID-19

CSL and Arcturus Therapeutics Report the EC’s Approval of Kostaive Against COVID-19

  • February 18, 2025
CSL Behring Receives the EC Approval for Andembry as a Prophylactic Treatment of HAE

CSL Behring Receives the EC Approval for Andembry as a Prophylactic Treatment of HAE

  • February 14, 2025
CSL Behring’s Andembry (Garadacimab) Receives Positive CHMP Opinion to Treat Hereditary Angioedema (HAE)

CSL Behring’s Andembry (Garadacimab) Receives Positive CHMP Opinion to Treat Hereditary Angioedema (HAE)

  • December 13, 2024
PharmaShots Weekly Snapshots (February 12 – February 16, 2024)

PharmaShots Weekly Snapshots (February 12 – February 16, 2024)

  • February 16, 2024
CSL Reports Top-line Data from the P-III (AEGIS-II) Study of CSL112 for Acute Myocardial Infarction (AMI)

CSL Reports Top-line Data from the P-III (AEGIS-II) Study of CSL112 for Acute Myocardial Infarction (AMI)

  • February 12, 2024
CSL & Arcturus Therapeutics Receives MHLW Approval for ARCT-154 to Treat COVID in Adults

CSL & Arcturus Therapeutics Receives MHLW Approval for ARCT-154 to Treat COVID in Adults

  • November 29, 2023
Insights+: EMA Marketing Authorization of New Drugs in February 2024

    Insights+: EMA Marketing Authorization of New Drugs in February 2024

    • March 20, 2024
    CSL Vifor and Travere Therapeutics’ Filspari (sparsentan) Gains CHMP’s Positive Opinion to Treat IgA Nephropathy

      CSL Vifor and Travere Therapeutics’ Filspari (sparsentan) Gains CHMP’s Positive Opinion to Treat IgA Nephropathy

      • February 23, 2024
      PharmaShots Weekly Snapshots (February 12 – February 16, 2024)

        PharmaShots Weekly Snapshots (February 12 – February 16, 2024)

        • February 16, 2024
        CSL Reports Top-line Data from the P-III (AEGIS-II) Study of CSL112 for Acute Myocardial Infarction (AMI)

          CSL Reports Top-line Data from the P-III (AEGIS-II) Study of CSL112 for Acute Myocardial Infarction (AMI)

          • February 12, 2024
          CSL & Arcturus Therapeutics Receives MHLW Approval for ARCT-154 to Treat COVID in Adults

            CSL & Arcturus Therapeutics Receives MHLW Approval for ARCT-154 to Treat COVID in Adults

            • November 29, 2023
            PharmaShots Weekly Snapshots (September 04–08, 2023)

              PharmaShots Weekly Snapshots (September 04–08, 2023)

              • September 8, 2023
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.